Introduction {#s1}
============

Neuroprostheses are becoming increasingly important for treatment of neurological disorders (Borton et al., [@B12]). Cochlear implants have restored hearing to hundreds of thousands of patients (Shannon, [@B60]). Deep brain stimulation has helped more than 100,000 patients suffering from Parkinson\'s disease and may treat numerous additional diseases (Lozano and Lipsman, [@B41]). Retinal prostheses restore basic visual percepts in patients with previously-untreatable conditions such as retinitis pigmentosa (Zrenner, [@B78]). Stimulation of the somatosensory cortex has been proposed to restore touch and proprioception in patients with prosthetic limbs (Bensmaia, [@B10]); a first demonstration in humans was recently reported and is expected to be published soon (Sanchez, [@B57]).

Current neuroprostheses address the nervous system by electrical stimulation. Other potential modalities include optical and chemical stimulation. A clinical trial investigating optogenetic treatment of retinitis pigmentosa in humans has begun (RetroSense Therapeutics, [@B80]; Bourzac, [@B79]), but challenges of low photosensitivity and targeting of specific retinal cells must be overcome and ethical issues and safety of human genetic modification must be addressed (Barrett et al., [@B7]). Chemical stimulation has been proposed (Iezzi and Finlayson, [@B32]) and supported by preliminary experiments (Finlayson and Iezzi, [@B20]; Inayat et al., [@B33]). Although, implantable drug delivery systems have been used clinically for decades (Penn and Kroin, [@B47]) and neural probes capable of drug delivery have been demonstrated (Frey et al., [@B21]; Altuna et al., [@B2]; Pongrácz et al., [@B49]), the distinct concept of *functional* chemical stimulation capable of mimicking neurotransmission remains inaccessible. The absence of suitable technology is the primary roadblock, which will be discussed in more detail below.

Neuronal signaling at chemical synapses
---------------------------------------

Neurons communicate with each other by the release of chemical neurotransmitters from the axonal terminal of presynaptic cells into the synaptic cleft (some neurons also use electrical synapses) (Purves et al., [@B51]). Release occurs by exocytosis of neurotransmitter-containing vesicles, triggered by an influx of calcium ions through voltage-gated channels which open upon depolarization of the axonal terminal by action potentials. Recognition of these chemical signals by specific, spatially-localized receptors in the postsynaptic membrane causes postsynaptic neurons to change their transmembrane potential in spatially-restricted areas, such as the synaptic cleft. Local changes of transmembrane potentials propagate across the cellular membrane, allowing integration of multiple synaptic inputs, and triggering successive neurotransmitter release to downstream neurons.

The specificity of chemical signaling relies on recognition of neurotransmitter by postsynaptic receptors. Prevention of continued stimulation of postsynaptic neurons requires removal of neurotransmitters from the extracellular volume. Most neurotransmitters are recycled by uptake into presynaptic neurons or degraded enzymatically.

Physiological concentrations of neurotransmitters cover at least seven orders of magnitude, from nanomolar to more than 100 mM (Featherstone, [@B19]). However, quantification of both synaptic and ambient extracellular concentrations is challenging (Scimemi and Beato, [@B58]; Sun et al., [@B67]). Peak synaptic glutamate concentrations are estimated to be in the low millimolar range (0.5--5 mM) (Featherstone, [@B19]). Nanomolar concentrations of ambient extracellular glutamate were predicted (Zerangue and Kavanaugh, [@B76]) and measured (Herman and Jahr, [@B27]). Other measurements revealed a wide range (25 nM to 10 μM), but higher concentrations are believed to result from damage due to the measurement technique (Sun et al., [@B67]).

Electrical stimulation
----------------------

Electrical neurostimulation depolarizes cells by extracellular voltage gradients generated by the spread of current injected into tissue by electrodes (Durand, [@B16]). Efforts have been made to target specific membrane areas or neuronal processes to modulate neuronal signaling by triggering or inhibiting release of neurotransmitters. However, electrical neurostimulation does not mimic physiological neurotransmission as the stimulating electric fields produce unspecific polarization of cells and act in large volumes compared to the size of synapses and neuronal processes. Electric fields may stimulate any cellular structures, depending on their spatial arrangement with nearby electrodes. This contrasts with neurotransmission, in which receptors on local areas of cell membranes respond to specific chemical signals. The main advantage of electrical stimulation compared to chemical stimulation is that the electrical field can be switched within microseconds at arbitrary locations. Technology to inject chemical signals with similar precision and speed does not exist, and chemical signals must rely on other mechanisms for removal.

Neuroprostheses rely on technology adapted from the microelectronics industry. Although modern nanofabrication achieves sub-10-nm resolution, extracellular neurostimulation electrodes maintain dimensions of tens of micrometers. The challenge of injecting sufficient current to excite neurons must be met while avoiding high voltages and dangerous side reactions (Merrill et al., [@B42]).

Preclinical experiments predicted a resolution limit of tens of micrometers for electrical stimulation of the retina (Stett et al., [@B63]). Intracortical microstimulation excites neurons hundreds of micrometers away from electrodes, although producing distinct percepts with closely-spaced electrodes has not been investigated (Bensmaia, [@B10]). Current retinal prostheses approach the predicted limits, with the Alpha IMS prosthesis (Retina Implant AG, Reutlingen, Germany) having 1500 electrodes with 70 μm pitch. The best artificial visual acuity demonstrated until now is 0.037 (Snellen acuity of 20/546), corresponding to a spatial resolution of 126 μm on the retina (Stingl et al., [@B64]). In comparison, visual acuity achieved by the fovea of healthy human retinas relies on photoreceptor cells with a pitch of \~5 μm (Hirsch and Curcio, [@B29]).

New electrode materials such as conducting polymers stimulate at lower voltages (Gerwig et al., [@B22]; Samba et al., [@B56]), which may enable the safe operation of smaller electrodes. Investigations with complex electrode configurations (Lorach et al., [@B40]) and guidance of neurons into features on artificial devices (Adekunle et al., [@B1]) are attempting to address these issues. However, a recent review emphasizes that electrical stimulation is not expected to restore visual acuity approaching normal vision (Eiber et al., [@B17]).

Recently, electrical recording and stimulation of single cells has been achieved by nanoscale electrodes (Angle et al., [@B3]), which may penetrate the cell membrane (Qing et al., [@B52]) or be engulfed (Hai et al., [@B25]). Reproduction of these results *in vivo* will be necessary to evaluate their potential for use in neuroprostheses. Although promising for high resolution stimulation, such methods would continue to rely on unphysiological mechanisms.

Progress toward chemical stimulation
------------------------------------

Researchers have long attempted to mimic neurotransmission. Neurotransmitter release from micropipettes by pressure injection or iontophoresis is an important technique for neurochemical investigations (Lalley, [@B36]). Such methods confirmed that delivery of glutamate produces physiological responses in retinas, supporting the concept of chemical-based prostheses (Finlayson and Iezzi, [@B20]; Inayat et al., [@B33]). Communicating in the extracellular language of neurons allows chemical stimulation to mimic real synaptic neurotransmission (Murnick et al., [@B44]; Finlayson and Iezzi, [@B20]; Iezzi and Finlayson, [@B32]; Inayat et al., [@B33]).

As with electrical neuroprostheses, advanced chemical stimulation devices would require dense integration by micro- or nanofabrication, which cannot be realized with micropipettes. Microfluidic devices for parallel chemical stimulation from an array of sites have been demonstrated, which release chemical stimuli through apertures addressed by buried channels (Peterman et al., [@B48]; Scott et al., [@B59]). Microfluidic devices were also proposed following pipette-based investigations (Inayat et al., [@B33]). A critical shortcoming of microfluidic devices is their failure to suppress leakage by diffusion. Although diffusion can be countered by applying ionic currents or withdrawal of the liquid, actively countering leakage of multiple channels would be prohibitively complex. Rather, blocking diffusion requires disrupting the aqueous phase with a phase barrier.

Actuation of a physical barrier is challenging in microfluidics. The classical Quake valve has been produced as small as 6 μm but requires multilayer soft lithography in monolithic structures (Araci and Quake, [@B4]). Solid barriers have been electrochemically opened but are not reversible (Chung et al., [@B14]). Air has been used to interrupt diffusion, but required a macroscopic gap which cannot be miniaturized or implanted (Zibek et al., [@B77]).

A further weakness of microfluidic stimulation is its low spatial resolution. Low spatial resolution hinders temporal resolution due to the so-called proximity effect (Iezzi and Finlayson, [@B32]). When diffusion is the primary transport mechanism, increasing distances cause exponential dilution and slowing of chemical signal transmission (e.g., latency of 1 s for 33 μm; Iezzi and Finlayson, [@B32]). Microfluidic or pipette-based release distant from target neurons clearly showed the latency of signal transmission (Peterman et al., [@B48]; Scott et al., [@B59]; Inayat et al., [@B33]). However, targeted iontophoretic stimulation of neuronal structures from \~100 nm pipette tips supports the possibility of fast chemical stimulation (Murnick et al., [@B44]).

No reported microfluidic technology can control single chemical release sites, and microfluidic structures provide insufficient resolution for communication with neurons. The challenge of controlling of chemical release sites for high resolution chemical release cannot be realized by microfluidics. Mimicry of physiological neurotransmission will require nanofluidic technology. The following section will discuss how nanopores could achieve synapse-like release.

Nanofluidic chemical release {#s2}
============================

The emphasis on *nano*fluidics is not surprising upon reviewing the physical mechanisms of neurotransmission. Neurotransmission relies on vesicular release of neurotransmitters, orchestrated by complex systems of molecular biology in the presynaptic neuron (Purves et al., [@B51]). Vesicles, 50 nm in diameter, contain up to 40,000 neurotransmitter molecules (Van der Kloot, [@B71]). Vesicular release occurs at specialized regions of synapses called active zones, with diameters of 200--500 nm (Südhof, [@B66]). Action potentials drive release of vesicles as fast as 2000 Hz (Kaeser and Regehr, [@B34]); although not sustainable, this rate can provide an upper estimate of release rates. The product of these values suggests an upper approximation for neurotransmitter release at an active zone of \~10^−16^ mol/s. A helpful comparison: if each molecule is a monovalent ion, this represents a current of 10 pA. The dimensions of active zones and their central role in neurotransmission make them an intriguing target for mimicry with an artificial nanopore device.

Replacement of the presynaptic neuron by an artificial device will require the capability of sustained release of at least the rate achieved by active zones. Real connections between devices and biology are never ideal, so higher release rates may be required to overcome reduced proximity. Release rates calculated below predict that nanofluidic elements can achieve physiologically-relevant release rates.

A notable property of synaptic release is its absolute nature. Vesicles enclose neurotransmitter molecules, and chemical transport across the cell membrane is strictly regulated. This contrasts with the limited gating capabilities achieved in artificial devices. Progress in nanofluidics has focused on nanopores: channels narrower than 100 nm fabricated perpendicularly through thin membranes. Exploitation of the influence of surface properties can control transport of ions or fluid, although electrostatic or steric effects have not achieved absolute shut-off (Taghipoor et al., [@B69]). A suitable technique to prevent diffusion requires a barrier to interrupt the aqueous phase. Hydrophobic gating could provide such a mechanism. Reports of relevant phenomena are discussed below to provide a perspective on what may be possible.

Nanofluidic release rates
-------------------------

An upper limit for vesicular release at single active zones was estimated above to be 10^−16^ mol/s, and provides a reference for discussion of nanofluidic release rates (Figure [1A](#F1){ref-type="fig"}). Another useful value is obtained from microiontophoresis, which can selectively stimulate single synapses to produce physiological responses (Murnick et al., [@B44]). Typical currents range from a few nanoamperes up to 100 nA (Lalley, [@B36]). Although direct quantification is challenging (Herr et al., [@B28]), converting 1 nA directly to monovalent ions is 10^−14^ mol/s (Figure [1A](#F1){ref-type="fig"}).

![**Nanofluidics may enable chemical release similar to vesicular release at synaptic active zones. (A)** Nanopores can release physiologically-relevant quantities. Release rates by diffusion and pressure-driven flow through nanopores with varying diameters are compared here to an upper estimate for release from a single synaptic active zone and iontophoresis. Calculations used a pore length of 500 nm, source concentration of 100 mM, and diffusivity of 10^−9^ m^2^/s. **(B)** Hydrophobic gating of nanopores may enable absolute control of chemical release without leakage by diffusion. **(C)** Simultaneous control of large numbers of pores will be necessary for neuroprostheses.](fnins-10-00138-g0001){#F1}

Diffusion and pressure may drive chemical release from a nanopore. Further discussion and derivation are available in the Supplementary Material. The release rate by diffusion, in mol/s, is $$\begin{array}{l}
{n_{D} = \frac{\pi c_{0}Dd^{2}}{4L},} \\
\end{array}$$ with source concentration *c*~0~, diffusivity *D*, and nanopore diameter *d* and length *L*. This expression assumes a linear concentration gradient along the length of the nanopore.

The release rate by applied pressure is $$\begin{array}{l}
{n_{P} = \frac{\pi c_{0}\Delta Pd^{4}}{128\eta L},} \\
\end{array}$$ with pressure Δ*P* and dynamic viscosity η. This expression assumes Hagen--Poiseuille flow without slip and neglects depletion or accumulation at the pore ends.

Example solutions are shown in Figure [1A](#F1){ref-type="fig"} for nanopores of various diameters, showing that nanopores can release chemicals at physiologically-relevant rates. This example uses a length of 500 nm, which would be sufficient to integrate electrodes or other functional elements. A 100 mM source is below synaptic vesicle concentrations. The release rates are sufficient to imitate synaptic transmission, given an appropriate method to turn release on and off.

Nanofluidic gating
------------------

Hydrophobic gating achieves absolute disruption of chemical transport by control of a vapor-phase barrier (Figure [1B](#F1){ref-type="fig"}). Although ubiquitous in cell membrane protein pores (Aryal et al., [@B5]), achieving similar effects in artificial nanopores has proven more challenging. Spontaneous nucleation of bubbles is prohibited in pores larger than a few nanometers in diameter, regardless of length (Lefevre et al., [@B38]; Guillemot et al., [@B24]). Top-down nanofabrication cannot achieve sufficient precision to mimic these dimensions. For example, hydrophobic gating in protein pores is affected by sub-nanometer changes in dimensions or single amino acid residue substitutions (Yoshimura et al., [@B74]; Beckstein and Sansom, [@B9]; Birkner et al., [@B11]).

Reversible hydrophobic gating in wider artificial nanopores has been demonstrated in response to applied electric fields (Powell et al., [@B50]; Smirnov et al., [@B61]). The reversibility demonstrated in these larger pores relies on trapping of bubbles within the pores (Smirnov et al., [@B62]), and their removal makes wetting irreversible. Deliberate bubble trapping by constrictions or surface chemistry has been suggested but not yet demonstrated (Smirnov et al., [@B62]; Guillemot et al., [@B24]). A hydrophobic liquid could provide an alternative to vapor bubbles; this concept has been demonstrated in macroscopic nanoporous membranes (Hou et al., [@B30]) but not in single nanopores. Reversibility could be achieved by generating bubbles by plasmonic heating (Li et al., [@B39]), Joule heating (Nagashima et al., [@B45]), or electrolysis (Chen et al., [@B13]).

As nanofluidic effects arise from surface properties, precise nanometer-scale control of structure and surface will be necessary to achieve desired functions. A leading example of artificial nanopore fabrication is a wafer-scale process for sub-20-nm-diameter pores with integrated electrodes (Bai et al., [@B6]). While most applications use homogenous surface chemistry, for example by silane-based modification (Miles et al., [@B43]), the molecular topography of such surfaces must not be overlooked (Fadeev and McCarthy, [@B18]). Long-term applications will require sufficient stability of nanopores\' structure and surface chemistry. Silicon nitride pores widen due to decomposition and dissolution (Rollings et al., [@B54]). In biological environments, protein adsorption presents further challenges (Yusko et al., [@B75]). Nanopores are usually investigated in isolation, and integration of arrays of nanopores remains a challenge. A recent report integrated five pores in individual microfluidic channels (Tahvildari et al., [@B70]).

These reports hint at what may be possible, while emphasizing the limited robustness and poor understanding of these effects. Robust and reversible nanopore electrowetting has not been demonstrated, and the mechanisms of electric-field-induced wetting of nanopores are not known. However, a generic mechanism can be envisioned (Figure [1B](#F1){ref-type="fig"}). A hydrophobic barrier will block chemical transport by formation of a phase barrier of vapor or a hydrophobic liquid. The Young--Laplace law explains the resistance to wetting of hydrophobic nanopores (Lee and Karnik, [@B37]), and has been verified in pores as narrow as 2.6 nm (Lefevre et al., [@B38]). A stimulus will form a water channel across the hydrophobic barrier, allowing chemical transport. This may be achieved by modulating the pore\'s surface energy or by applying sufficient pressure or voltage to force water into the pore. Dewetting may occur spontaneously or may be driven, for example by heating. For applications in neuroprotheses, control of many nanopores simultaneously must be achieved (Figure [1C](#F1){ref-type="fig"}).

Propagation of chemical signals {#s3}
===============================

Propagation of chemical signals occurs throughout the nervous system with diverse spatial and temporal scales (Syková and Nicholson, [@B68]; Vizi and Lendvai, [@B72]; Rusakov et al., [@B55]). Neurotransmitters diffuse across the synaptic cleft (\~20 nm) faster than 1 μs; diffusion also drives volume transmission over larger distances at time scales of minutes or longer. Extracellular diffusion can be studied by iontophoretic injection and electrochemical detection of a tracer molecule (Nicholson et al., [@B46]). The diffusion equation can be modified to consider extracellular volume fraction and tortuosity, but such approximations are invalid in specific micro- or nanoscale geometries. Moreover, uptake and enzymatic reactions influence extracellular chemical signals.

The synapses of cone photoreceptor cells demonstrate the potential complexity of nanoscale chemical signal transmission (Regus-Leidig and Brandstätter, [@B53]). Neurotransmitter release from these neurons addresses multiple postsynaptic cells, whose responses depend on their spatial proximity to the active zone. Postsynaptic dendrites localized at the active zone receive rapid high neurotransmitter concentrations, while cells which contact the photoreceptors farther from the active zone receive smoother, lower concentrations. The responses of these postsynaptic neurons correlate with the nanoscale propagation of neurotransmitter.

The proximity effect is a challenge for chemical stimulation: diffusive transport to larger distances requires exponentially longer times and leads to exponential dilution (Iezzi and Finlayson, [@B32]). The dimensions of microfluidic chemical stimulation devices suggest a limit of seconds to minutes. However, the chemical communication mechanisms of the brain prove the capability of delivering chemical information over diverse spatial and temporal dimensions. Slow volume transmission across large distances (Syková and Nicholson, [@B68]) could provide a target for neuromodulatory chemical neuroprostheses. Fast, high resolution stimulation requires intimate contact with cells (Murnick et al., [@B44]).

Chemical signal propagation from nanopores may be illustrated by analytical solutions to the diffusion equation (Crank, [@B15]). Expressions for instantaneous or continuous release from a point source are described in the Supplementary Material and illustrated in Figure [2](#F2){ref-type="fig"}. Figure [2B](#F2){ref-type="fig"} shows the rapid rise and fall of a chemical impulse, with micrometer-scale resolution and millisecond-scale time course. Figure [2C](#F2){ref-type="fig"} shows the propagation of constant diffusion from a nanopore with diameter of 50 nm and length of 500 nm, and release by diffusion only (4·10^−16^ mol/s). High concentrations rapidly establish near the source, while spread to larger distances is slower. Concentrations at larger distances are limited by continuous diffusion to a steady-state limit. Long release times cannot produce concentrated signals at large distances from a nanopore.

![**Release and spread of chemical signals from nanopores by diffusion. (A)** The physical setup of a single nanopore with diameter of 50 nm and length of 500 nm. **(B)** Propagation of an instantaneous chemical impulse of 10^6^ molecules at *t* = 0. Concentrations 1 μm away from the nanopore source rise and fall by orders of magnitudes within milliseconds**. (C)** Propagation of constant release from a nanopore, illustrated in **(A)**, turned on at *t* \> 0. A high concentration is established quickly near the nanopore. At larger distances, the concentration approaches a steady state, which is diluted by orders of magnitude in comparison to the concentration within 1 μm of the nanopore. **(D)** A dense array of nanopores can be resolved at close distances. Here, the release rate at each nanopore is the same as in **(C)** and the nanopores are separated by 10 μm. Color scale is logarithmic and shown in discrete steps for clarity. A reproduction with a linear color scale is available as Figure [1S](#SM1){ref-type="supplementary-material"} in the Supplementary Material.](fnins-10-00138-g0002){#F2}

The analytical solution for continuous release also provides an estimate of potential density of independent nanopores. Figure [2D](#F2){ref-type="fig"} illustrates this for an array of nanopores with a pitch of 10 μm. At close distances, the signals are clearly resolved, while larger distances obscure the individual signals. This analytical solution provides only an estimate, without considering interference of the neighboring pores. Improved accuracy of time-varying chemical release from multiple nanopores could be obtained by numerical simulation, which could permit inclusion of cellular structures (Hepburn et al., [@B26]).

Conclusion/outlook {#s4}
==================

The clinical success of electrical neuroprostheses has proven the possibility to treat neurological disorders with artificial devices, while also revealing limitations of addressing complex physiology with comparatively simple electrical methods. Neurotransmitter-based stimulation could enable the ultimate neuroprosthesis by addressing neurons with their own chemical language.

The challenges to be overcome must not be underestimated. The field of microfluidics remains immature in comparison to microelectronics (Becker, [@B8]; Whitesides, [@B73]). Nanofluidics has remained especially unexplored due to limitations of fabrication (Whitesides, [@B73]). Neurotransmitter-based stimulation will require continued developments of microfluidics and nanofluidics. The development of nanoelectrodes (Angle et al., [@B3]) may provide an indication of the challenges involved in interfacing nanoscale devices with biological systems. However, while electrode development may benefit from expertise of the nanoelectronics industry, similarly mature expertise in nanofluidics does not exist.

A robust nanofluidic gating mechanism is required. Hydrophobic gating may provide the mechanism, although a robust realization of this effect may be different from what has been reported until now. Reliable fabrication and operation of thousands of individual pores must be demonstrated. Large scale integration of individually controlled nanopores with microfluidic and electrical control will be necessary. Certainly, many generations of technology development will precede the realization of the goal of chemical neuroprostheses.

Some challenges can be predicted. Long-term operation in aggressive biological environments will be necessary for the goal of neuroprostheses. The requirement for intimate proximity with target neurons may require advanced biochemical functionalization of the device or release of neurotrophic factors to encourage the neurons\' acceptance of an artificial device. Removal of chemical signals must be investigated to avoid excitotoxicity, although surrounding cells may accomplish this, for example by the widely-expressed excitatory amino acid transporters in the retina (Iezzi and Finlayson, [@B32]).

The complexity of the brain raises an important question: Do we understand the brain well-enough to rationally stimulate it with high resolution chemical signals? Stimulation of well-understood structures including the retina or sensory cortex should be possible (Iezzi and Finlayson, [@B32]; Bensmaia, [@B10]). However, deep brain stimulation protocols continue to rely on trial-and-error optimization with patient feedback (Kringelbach et al., [@B35]). Neurons integrate inputs of up to hundreds of thousands of synapses (Stuart and Spruston, [@B65]). If nanopores are envisioned to replace single synaptic inputs, an artificial device cannot be expected to interface with complex brain areas. However, as "megascience" efforts turn their focus to neuroscience, coming years may see an acceleration of our understanding of the brain (Grillner, [@B23]) which may reveal new possibilities for treatment of neurological disorders by artificial chemical stimulation.
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